Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05043051 · ClinicalTrials.gov registry record · NA
Autoimmune Basis for Postural Tachycardia Syndrome
A NA study of Postural Tachycardia Syndrome, sponsored by University of Oklahoma.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT05043051 is a NA study of Postural Tachycardia Syndrome that is actively recruiting participants, run by University of Oklahoma. The registered enrollment target is 80 participants, roughly in line with the 78-participant average among 19 other Postural Tachycardia Syndrome trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT05043051, a NA study of Postural Tachycardia Syndrome, is actively recruiting participants, sponsored by University of Oklahoma.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test the hypothesis that an antibody-mediated autoimmune reaction will cause symptoms of autonomic dysfunction in some patients with postural tachycardia syndrome (POTS). The investigators further hypothesize that electrical stimulation of the vagus nerve will improve POTS symptoms, autoimmunity and inflammation.
Conditions Studied
Interventions
- DEVICE Sham stimulation
- DEVICE Vagal stimulation
Study Locations (1)
Oklahoma
- Oklahoma Clinical and Translational Science Institute - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2022-01-14 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05043051
The ClinicalTrials.gov registry entry for NCT05043051 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 78-participant average among 19 other Postural Tachycardia Syndrome trials with a reported enrollment target. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Postural Tachycardia Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Sham stimulation is the first listed.
NCT05043051 reports 1 study location spanning 1 distinct geographic area - top geographies include Oklahoma.
Frequently Asked Questions
What is clinical trial NCT05043051 about?
NCT05043051 is a clinical study titled "Autoimmune Basis for Postural Tachycardia Syndrome". The purpose of this study is to test the hypothesis that an antibody-mediated autoimmune reaction will cause symptoms of autonomic dysfunction in some patients with postural tachycardia syndrome (POTS). The investigators further hypothesize that electrical stimulation of the vagus nerve will improve...
What is the current status of trial NCT05043051?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2022-01-14. Estimated completion is 2026-07-31.
What conditions does trial NCT05043051 study?
This clinical trial studies the following conditions: Postural Tachycardia Syndrome.
What interventions are being tested in trial NCT05043051?
The interventions under investigation include: Sham stimulation (DEVICE), Vagal stimulation (DEVICE).
Who is sponsoring clinical trial NCT05043051?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05043051 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postural Tachycardia Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Periaqueductal Gray-vagus Nerve Interface Malfunction Explain the Natural History With Its Numerous Co-morbidities?
RECRUITING · NA
-
Intravenous (IV) Saline and Exercise in Postural Tachycardia Syndrome (POTS)
ACTIVE NOT RECRUITING · NA
-
Acute Salt Handling in Orthostatic Intolerance
ACTIVE NOT RECRUITING · NA
-
fMRI in Postural Tachycardia Syndrome
ACTIVE NOT RECRUITING · NA
-
Aldosterone & Sodium Regulation in Postural Tachycardia Syndrome - Screening
ACTIVE NOT RECRUITING · NA
-
Breathing Device in Postural Orthostatic Tachycardia Syndrome (POTS)
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.